Abstract: A lead-acid battery management system and a lead-acid battery management program are described that appropriately manage bipolar lead-acid batteries to reduce a degree to which the lead-acid batteries impose a load on environment as much as possible and are necessary to cause a circulation cycle from manufacturing to reuse to reliably function. A lead-acid battery system includes multiple bipolar lead-acid batteries and a management and support apparatus configured to manage the lead-acid battery system. The management and support apparatus includes a recording unit configured to record operation history information of the bipolar lead-acid batteries and a state determination unit configured to determine necessity of replacement of respective ones of the bipolar lead-acid batteries.

Abstract: A novel tumor antigen protein and gene therefor, tumor antigen peptides derived from said tumor antigen protein or derivatives thereof as well as medicaments, prophylactics, or diagnostics for tumors using such tumor substances in vitro or in vitro are provided.

Abstract: A novel tumor antigen protein and gene therefor, tumor antigen peptides derived from said tumor antigen protein or derivatives thereof as well as medicaments, prophylactics, or diagnostics for tumors using such tumor substances in vitro or in vitro are provided.

Abstract: A novel tumor antigen protein and gene therefor, tumor antigen peptides derived from said tumor antigen protein or derivatives thereof as well as medicaments, prophylactics, or diagnostics for tumors using such tumor substances in vitro or in vitro are provided.

Abstract: A novel tumor antigen protein and gene therefor, tumor antigen peptides derived from said tumor antigen protein or derivatives thereof as well as medicaments, prophylactics, or diagnostics for tumors using such tumor substances in vitro or in vitro are provided.

Abstract: A novel tumor antigen protein and gene therefor, tumor antigen peptides derived from said tumor antigen protein or derivatives thereof as well as medicaments, prophylactics, or diagnostics for tumors using such tumor substances in vitro or in vitro are provided.

Abstract: A novel tumor antigen protein and gene therefor, tumor antigen peptides derived from said tumor antigen protein or derivatives thereof as well as medicaments, prophylactics, or diagnostics for tumors using such tumor substances in vitro or in vitro are provided.

Abstract: A novel tumor antigen protein and gene therefor, tumor antigen peptides derived from said tumor antigen protein or derivatives thereof as well as medicaments, prophylactics, or diagnostics for tumors using such tumor substances in vitro or in vitro are provided.

Abstract: A novel tumor antigen protein and gene therefor, tumor antigen peptides derived from said tumor antigen protein or derivatives thereof as well as medicaments, prophylactics, or diagnostics for tumors using such tumor substances in vitro or in vitro are provided.

Abstract: To provide a tumor antigen peptide derived from SART-1 and a derivative thereof, possessing functionally equivalent characteristics thereto; or a therapeutic agent, prophylactic agent or the like for a tumor, each utilizing, the tumor antigen peptide.